Flagship explainer
What drives NeuroOne Medical Technologies Corporation’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$3.6M | FY2025 |
| |
| Income before tax | −$3.6M | FY2025 |
|
| Operating income | −$4.2M | FY2025 |
|
| $9.1M | FY2025 |
| |
| Ending assets | $10.8M | FY2025 |
|
| Beginning assets | $5.4M | FY2024 |
|
| $7.1M | FY2025 |
| |
| $822013 | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001213900-25-122390